These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4536624)

  • 1. Angiogenesis in progressive systemic sclerosis.
    Siegel RC
    N Engl J Med; 1972 Jan; 286(4):217. PubMed ID: 4536624
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anticentromere antibodies and other antinuclear antibodies in progressive systemic sclerosis].
    Rojas C; Silva MC; Pérez L; Ruiz F
    Rev Med Chil; 1985 May; 113(5):409-14. PubMed ID: 3912881
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum antinuclear antibodies (in patients with visceral erythematodes, rheumatoid arthritis, progressive systemic sclerosis and discoid erythematodes)].
    Horvat Z
    Acta Med Iugosl; 1970; 24(3):229-40. PubMed ID: 4928076
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathogenesis of progressive systemic sclerosis.
    Haustein UF; Herrmann K; Böhme HJ
    Int J Dermatol; 1986 Jun; 25(5):286-93. PubMed ID: 3522447
    [No Abstract]   [Full Text] [Related]  

  • 5. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C; Mejía Arreguín S; Orozco Medina JH; González Mendoza A
    Rev Invest Clin; 1984; 36(2):115-9. PubMed ID: 6385174
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antinuclear antibody profile in progressive systemic sclerosis. A multicenter study].
    Martínez-Cordero E; Burgos-Vargas R; Herrera-Esparza R; Reyes PA
    Rev Invest Clin; 1983; 35(4):273-7. PubMed ID: 6369466
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antinuclear antibody profile of progressive systemic sclerosis].
    Dong Y; Chen PZ; Chen M
    Zhonghua Nei Ke Za Zhi; 1987 Mar; 26(3):155-7, 190. PubMed ID: 3497783
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of anti-Scl-70 antibody and its clinical significance in progressive systemic sclerosis.
    Jiang M; Song QF; Wang SZ; Yuan X; Zhang NZ
    Proc Chin Acad Med Sci Peking Union Med Coll; 1986; 1(4):247-9. PubMed ID: 3124097
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of anti-Scl-70 antibody and its clinical significance in progressive systemic sclerosis].
    Jiang M
    Zhonghua Yi Xue Za Zhi; 1986 Jun; 66(6):346-8, 384. PubMed ID: 3094898
    [No Abstract]   [Full Text] [Related]  

  • 10. Connective tissue disease in India. III. Clinical and immunological profile of progressive systemic sclerosis.
    Malaviya AN; Adhar GC; Pasricha JS
    J Assoc Physicians India; 1979 May; 27(5):395-400. PubMed ID: 316815
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nuclear antibodies as serologic markers in progressive systemic scleroderma].
    Lakomek HJ; Guldner HH; Bautz FA; Goerz G; Kind P; Mensing H; Krüskemper HL
    Hautarzt; 1987 Feb; 38(2):63-9. PubMed ID: 3106261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiochemical demonstration of serum antibodies against double stranded DNA in progressive and circumscribed scleroderma].
    Meffert H; Falck P; Sönnichsen N
    Dermatol Wochenschr; 1975 Sep; 161(9):771-2. PubMed ID: 1081055
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antinuclear antibodies in patients with systemic scleroderma].
    Wranicz A; Defecińska-Trzeciak E
    Przegl Dermatol; 1972; 59(3):315-20. PubMed ID: 4538127
    [No Abstract]   [Full Text] [Related]  

  • 14. [Profile of antibodies against nuclear and polynucleotide antigens in diffuse scleroderma].
    Zitnan D; Cebecauer L; Rovenský J; Lukác J
    Cas Lek Cesk; 1982 Nov; 122(45):1392-7. PubMed ID: 6196115
    [No Abstract]   [Full Text] [Related]  

  • 15. Familial progressive systemic sclerosis (scleroderma): immunological analysis of two patients and six siblings from a single kindred.
    Soppi E; Lehtonen A; Toivanen A
    Clin Exp Immunol; 1982 Nov; 50(2):275-82. PubMed ID: 6217932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current findings in progressive systemic sclerosis].
    Zanussi C; Ortolani C; Pastorello E; Riboldi PS; Sabbadini MG
    Minerva Med; 1982 Apr; 73(18):1189-200. PubMed ID: 7043320
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antinuclear antibodies in progressive systemic sclerosis].
    Sepúlveda C; Palma S; Guzmán L; Bravo M
    Rev Med Chil; 1986 Aug; 114(8):731-6. PubMed ID: 3554436
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunologic findings in progressive scleroderma--diagnostic and nosologic significance].
    Sönnichsen N; Brenke A; Barthelmes H; Albrecht-Nebe H; Diezel W
    Dermatol Monatsschr; 1983 Jun; 169(6):385-93. PubMed ID: 6603989
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
    Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANA in progressive systemic sclerosis.
    Giordano M; Tirri G; Migliaresi S; Picillo U
    Ann Rheum Dis; 1983 Feb; 42(1):111-2. PubMed ID: 6600912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.